She QB, Solit DB, Ye Q, et al. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells[J]. Cancer Cell, 2005, 8(4): 287-297.
[2]
Ellert-Miklaszewska A, Kaminska B, Konarska L. Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein[J]. Cell Signal, 2005, 17(1): 25-37.
[3]
Virdee K, Parone PA, Tolkovsky AM. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival[J]. Curr Biol, 2000, 10(23): R883.
[4]
Kim MR, Jeong EG, Chae B, et al. Pro-apoptotic PUMA and anti-apoptotic phospho-BAD are highly expressed in colorectal carcinomas[J]. Dig Dis Sci, 2007, 52(10): 2751-2756.
[5]
Sinicrope FA, Rego RL, Foster NR, et al. Proapoptotic Bad and Bid protein expression predict survival in stages Ⅱ and Ⅲ colon cancers[J]. Clin Cancer Res, 2008, 14 (13): 4128-4133.
[6]
Yoo NJ, Lee JW, Jeong EG, et al. Expressional analysis of anti-apoptotic phospho-BAD protein and mutational analysis of pro-apoptotic BAD gene in hepatocellular carcinomas[J]. Dig Liver Dis, 2006, 38(9): 683-687.
Marzo I, Naval J. Bcl-2 family members as molecular targets in cancer therapy[J]. Biochem Pharmacol, 2008, 76(8): 939-946.
[14]
Yang E, Zha J, Jockel J, et al. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death[J]. Cell, 1995, 80(2): 285-291.
[15]
Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy[J]. Oncogene, 2007, 26(9): 1324-1337.
[16]
Niquet J, Wasterlai, CG. Bim, BAD, and Bax: a deadly combination in epileptic seizures[J]. J Clin Invest, 2004, 113(7): 960-962.
[17]
Lindsay J, Esposti MD, Gilmore AP. Bcl-2 proteins and mitochondria-Specificity in membrane targeting for death[J]. Biochim Biophys Acta, 2011, 1813(4): 532-539.
[18]
Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery[J]. Cell, 1997, 91(2): 231-241.
Jin Z, Gao F, Flagg T, et al. Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis[J]. J Biol Chem, 2004, 279(22): 23837-23844.
[22]
Su JC, Lin KL, Chien CM,et al. Naphtho[1, 2-b]furan-4, 5-dione inactivates EGFR and PI3K/Akt signaling pathways in human lung adenocarcinoma A549 cells[J]. Life Sci, 2010, 86(5-6): 207-213.
[23]
Al-Bazz YO, Underwood JC, Brown BL, et al. Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer[J]. Eur J Cancer, 2009, 45(4): 694-704.
Yu B, Sun X, Shen HY, et al. Expression of the apoptosis-related genes BCL-2 and BAD in human breast carcinoma and their associated relationship with chemosensitivity[J]. J Exp Clin Cancer Res, 2010, 29: 107.
[26]
Khor TO, Gul YA, Ithnin H, et al. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma[J]. Cancer Lett, 2004, 210(2): 139-150.
[27]
Soung YH, Lee JW, Park WS, et al. BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder[J]. Pathology, 2006, 38(1): 33-34.
